Correlation of C4ST-1 and ChGn-2 expression with chondroitin sulfate chain elongation in atherosclerosis

Biochemical and Biophysical Research Communications

Volumn 406, Issue 1, 2011, Pages 36-41

  Anggraeni, Vita Yanti ^a   Emoto, Noriaki ^a,b   Yagi, Keiko ^b   Mayasari, Dyah Samti ^a   Nakayama, Kazuhiko ^b   Izumikawa, Tomomi ^b   Kitagawa, Hiroshi ^b   Hirata, Ken ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Chondroitin 4 O sulfotransferase 1; Chondroitin N acetylgalactosaminyltransferase 2; Chondroitin sulfate; Glycosaminoglycans; Proteoglycans

Indexed keywords

APOLIPOPROTEIN B; BIGLYCAN; CHONDROITIN 4 O SULFOTRANSFERASE 1; CHONDROITIN 4 SULFATE; CHONDROITIN ABC LYASE; DISACCHARIDE; GLYCOSAMINOGLYCAN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; N ACETYLGALACTOSAMINYLTRANSFERASE; N ACETYLGALACTOSAMINYLTRANSFERASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE COURSE; GEL FILTRATION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSLATION;

ANIMALS; AORTA; ATHEROSCLEROSIS; BIGLYCAN; CHONDROITIN SULFATES; LIPOPROTEINS, LDL; MICE; MICE, KNOCKOUT; N-ACETYLGALACTOSAMINYLTRANSFERASES; RECEPTORS, LDL; SULFOTRANSFERASES;

MUS;

EID: 79952184592     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.096     Document Type: Article

References (44)

1. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 1995, 15:551-561.
2. Tabas I., Williams K.J., Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007, 116:1832-1844.
3. Chait A., Wight T.N. Interaction of native and modified low-density lipoproteins with extracellular matrix. Curr. Opin. Lipidol. 2000, 11:457-463.
4. Germaã¡n C., Eva H.-C., Olov W., et al. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 1998, 139:205-222.
5. Williams K.J. Arterial wall chondroitin sulfate proteoglycans: diverse molecules with distinct roles in lipoprotein retention and atherogenesis. Curr. Opin. Lipidol. 2001, 12:477-487.
6. Nakashima Y., Wight T.N., Sueishi K. Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans. Cardiovasc. Res. 2008, 79:14-23.
7. Dadlani H., Ballinger M.L., Osman N., et al. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle. J. Biol. Chem. 2008, 283:7844-7852.
8. Getachew R., Ballinger M.L., Burch M.L., et al. PDGF {beta}-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL. Endocrinology 2010, 151:4356-4367.
9. Ivey M.E., Little P.J. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways. Thromb. Res. 2008, 123:288-297.
10. Ballinger M.L., Nigro J., Frontanilla K.V., et al. Regulation of glycosaminoglycan structure and atherogenesis. Cell. Mol. Life Sci. 2004, 61:1296-1306.
11. Little P.J., Ballinger M.L., Osman N. Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis. Vasc. Health Risk Manage. 2007, 3:117-124.
12. Silbert J.E., Sugumaran G. Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life 2002, 54:177-186.
13. Izumikawa T., Okuura Y., Koike T., Kitagawa H. Chondrotin 4-O-sulfotransferase-1 regulates the chain length of chondroitin sulfate in cooperation with chondroitin N-acetylgalactosaminyltransferase-2. Biochem. J. 2011, 434:321-331.
14. Izumikawa T., Koike T., Shiozawa S., et al. Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization. J. Biol. Chem. 2008, 283:11396-11406.
15. Kitagawa H., Izumikawa T., Uyama T., et al. Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization. J. Biol. Chem. 2003, 278:23666-23671.
16. Izumikawa T., Uyama T., Okuura Y., Sugahara K., Kitagawa H. Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor. Biochem. J. 2007, 403:545-552.
17. Plump A.S., Scott C.J., Breslow J.L. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 1994, 91:9607-9611.
18. Nadanaka S., Ishida M., Ikegami M., et al. Chondroitin 4-O-sulfotransferase-1 modulates Wnt-3a signaling through control of E disaccharide expression of chondroitin sulfate. J. Biol. Chem. 2008, 283:27333-27343.
19. Uyama T., Ishida M., Izumikawa T., et al. Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity. J. Biol. Chem. 2006, 281:38668-38674.
20. Kitagawa H., Kinoshita A., Sugahara K. Microanalysis of glycosaminoglycan-derived disaccharides labeled with the fluorophore 2-aminoacridone by capillary electrophoresis and high-performance liquid chromatography. Anal. Biochem. 1995, 232:114-121.
21. Koike T., Izumikawa T., Tamura J.I., et al. FAM20B is a kinase that phosphorylates xylose in the glycosaminoglycan protein linkage region. Biochem. J. 2009, 421:157-162.
22. Sorrell J., Mahmoodian F., Schafer I., et al. Identification of monoclonal antibodies that recognize novel epitopes in native chondroitin/dermatan sulfate glycosaminoglycan chains: their use in mapping functionally distinct domains of human skin. J. Histochem. Cytochem. 1990, 38:393-402.
23. Huang W.-C., Kuo W.-C., Cherng J.-H., et al. Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem. Biophys. Res. Commun. 2006, 349:963-968.
24. Nakashima Y., Chen Y.-X., Kinukawa N., et al. Distributions of diffuse intimal thickening in human arteries: preferential expression in atherosclerosis-prone arteries from an early age. Virchows Arch. 2002, 441:279-288.
25. Yla-Herttuala S., Solakivi T., Hirvonen J., et al. Glycosaminoglycans and apolipoproteins B and A-I in human aortas. Chemical and immunological analysis of lesion-free aortas from children and adults. Arterioscler. Thromb. Vasc. Biol. 1987, 7:333-340.
26. O'Brien K.D., Olin K.L., Alpers C.E., Chiu W., Ferguson M., Hudkins K., Wight T.N., Chait A. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation 1998, 98:519-527.
27. Wight T.N., Merrilees M.J. Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ. Res. 2004, 94:1158-1167.
28. Tannock L., King V. Proteoglycan mediated lipoprotein retention: a mechanism of diabetic atherosclerosis. Rev. Endocr. Metab. Dis. 2008, 9:289-300.
29. Schonherr E., Jarvelainen H., Kinsella M., et al. Platelet-derived growth factor and transforming growth factor-ft differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1993, 1995:1026-1036.
30. Hiraoka N., Nakagawa H., Ong E., et al. Molecular cloning and expression of two distinct human chondroitin 4-O-sulfotransferases that belong to the HNK-1 sulfotransferase gene family. J. Biol. Chem. 2000, 275:20188-20196.
31. Uyama T., Kitagawa H., Tanaka J., Tamura J.-i., Ogawa T., Sugahara K. Molecular cloning and expression of a second chondroitin N-acetylgalactosaminyltransferase involved in the initiation and elongation of chondroitin/dermatan sulfate. J. Biol. Chem. 2003, 278:3072-3078.
32. Nakashima Y., Fujii H., Sumiyoshi S., et al. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1159-1165.
33. Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993, 98:1-9.
34. Hoff H.F., O'Neil J.A. Oxidation of LDL: role in atherogenesis. Klin. Wochenschr. 1991, 69(21-23):1032-1038.
35. Hurt-Camejo E., Camejo G., Rosengren B., et al. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1992, 12(5):569-583.
36. Kaplan M., Aviram M. Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages: an alternative approach to study lipoproteins cellular uptake. Arterioscler. Thromb. Vasc. Biol. 2001, 21:386-393.
37. Chang M.Y., Potter-Perigo S., Tsoi C., et al. Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. J. Biol. Chem. 2000, 275:4766-4773.
38. Skalen K., Gustafsson M., Rydberg E.K., et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002, 417:750-754.
39. Bancells C., Benã-tez S.n., Jauhiainen M., et al. High binding affinity of electronegative LDL to human aortic proteoglycans depends on its aggregation level. J. Lipid Res. 2009, 50:446-455.
40. Figueroa J.E., Vijayagopal P. Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties. Atherosclerosis 2002, 162:261-268.
41. Gustafsson M., Levin M., Skalen K., et al. Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase. Circ. Res. 2007, 101:777-783.
42. Khalil M.F., Wagner W.D., Goldberg I.J. Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2211-2218.
43. Pentikainen M.O., Oksjoki R., Oorni K., et al. Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more. Arterioscler. Thromb. Vasc. Biol. 2002, 22:211-217.
44. Hashimura K., Sudhir K., Nigro J., et al. Androgens stimulate human vascular smooth muscle cell proteoglycan biosynthesis and increase lipoprotein binding. Endocrinology 2005, 146:2085-2090.